New advances of TMEM88 in cancer initiation and progression, with special emphasis on Wnt signaling pathway-Reference-Cited by-全球学者库

New advances of TMEM88 in cancer initiation and progression, with special emphasis on Wnt signaling pathway

Author:

Ge Yun‐xuan¹²,Wang Chang‐hui³⁴,Hu Fu‐yong⁵,Pan Lin‐xin⁶,Min Jie⁷,Niu Kai‐yuan⁸,Zhang Lei²,Li Jun²,Xu Tao²^ORCID

Affiliation:

1. Beijing Institute of Radiation MedicineAcademy of Military Medical SciencesBeijingChina

2. School of Pharmacy, Institute for Liver Diseases of Anhui Medical UniversityAnhui Medical UniversityHefeiChina

3. Department of CardiologyFirst Affiliated Hospital of Anhui Medical UniversityHefeiChina

4. School of Basic Medical SciencesAnhui Medical UniversityHefeiChina

5. The Second People's Hospital of Hefei & Affiliated Hospital of Medical University of AnhuiHefeiChina

6. School of Life SciencesAnhui Medical UniversityHefeiChina

7. Department of UrologyThe Second Affiliated Hospital of Anhui Medical UniversityHefeiChina

8. Department of OtolaryngologyThe Third Affiliated Hospital of Anhui Medical UniversityHefeiAnhuiChina

Funder

National Natural Science Foundation of China

Provincial Foundation for Excellent Young Talents of Colleges and Universities of Anhui Province

Anhui Medical University

Guangdong Medical Research Foundation

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

Reference49 articles.

1. Treatment of refractory and recurrent ovarian cancer;Alberts D. S.;Seminars in Oncology,1999

2. Breast Cancer Screening (PDQ(R)): Patient Version.2002. In PDQCancer Information Summaries. Bethesda (MD).

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献